JP2017512069A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017512069A5 JP2017512069A5 JP2016570925A JP2016570925A JP2017512069A5 JP 2017512069 A5 JP2017512069 A5 JP 2017512069A5 JP 2016570925 A JP2016570925 A JP 2016570925A JP 2016570925 A JP2016570925 A JP 2016570925A JP 2017512069 A5 JP2017512069 A5 JP 2017512069A5
- Authority
- JP
- Japan
- Prior art keywords
- risk
- patient
- low
- abcc3
- genotype
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 29
- 102100028162 ATP-binding cassette sub-family C member 3 Human genes 0.000 claims 21
- 101000986633 Homo sapiens ATP-binding cassette sub-family C member 3 Proteins 0.000 claims 21
- 208000031649 Postoperative Nausea and Vomiting Diseases 0.000 claims 16
- 230000035772 mutation Effects 0.000 claims 16
- 208000004756 Respiratory Insufficiency Diseases 0.000 claims 15
- 206010038678 Respiratory depression Diseases 0.000 claims 15
- 230000002411 adverse Effects 0.000 claims 14
- 230000007614 genetic variation Effects 0.000 claims 13
- 239000003795 chemical substances by application Substances 0.000 claims 10
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims 10
- 102100029111 Fatty-acid amide hydrolase 1 Human genes 0.000 claims 6
- 101000937693 Homo sapiens Fatty acid 2-hydroxylase Proteins 0.000 claims 6
- 101000918494 Homo sapiens Fatty-acid amide hydrolase 1 Proteins 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 5
- 229960005181 morphine Drugs 0.000 claims 5
- 101710163270 Nuclease Proteins 0.000 claims 4
- 230000002035 prolonged effect Effects 0.000 claims 4
- 238000011084 recovery Methods 0.000 claims 4
- 108700028369 Alleles Proteins 0.000 claims 3
- 239000003298 DNA probe Substances 0.000 claims 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 230000002068 genetic effect Effects 0.000 claims 3
- 230000036592 analgesia Effects 0.000 claims 2
- 230000000202 analgesic effect Effects 0.000 claims 2
- 239000000730 antalgic agent Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 238000003205 genotyping method Methods 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 229940035676 analgesics Drugs 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 238000004166 bioassay Methods 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 229940121367 non-opioid analgesics Drugs 0.000 claims 1
- 239000000014 opioid analgesic Substances 0.000 claims 1
- 229940005483 opioid analgesics Drugs 0.000 claims 1
- 229940124636 opioid drug Drugs 0.000 claims 1
- 238000003752 polymerase chain reaction Methods 0.000 claims 1
- 238000007670 refining Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461943944P | 2014-02-24 | 2014-02-24 | |
| US61/943,944 | 2014-02-24 | ||
| PCT/US2015/017134 WO2015127379A1 (en) | 2014-02-24 | 2015-02-23 | Methods and compositions for personalized pain management |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017512069A JP2017512069A (ja) | 2017-05-18 |
| JP2017512069A5 true JP2017512069A5 (enExample) | 2018-04-05 |
| JP6581117B2 JP6581117B2 (ja) | 2019-09-25 |
Family
ID=52597325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016570925A Expired - Fee Related JP6581117B2 (ja) | 2014-02-24 | 2015-02-23 | 個別化疼痛管理のための方法及び組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10878939B2 (enExample) |
| EP (1) | EP3110968B1 (enExample) |
| JP (1) | JP6581117B2 (enExample) |
| KR (1) | KR20160123385A (enExample) |
| CN (1) | CN106460042A (enExample) |
| AU (1) | AU2015218692A1 (enExample) |
| CA (1) | CA2940422A1 (enExample) |
| IL (1) | IL247389A0 (enExample) |
| SG (1) | SG11201607035YA (enExample) |
| WO (1) | WO2015127379A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8930178B2 (en) | 2007-01-04 | 2015-01-06 | Children's Hospital Medical Center | Processing text with domain-specific spreading activation methods |
| EP2785874B1 (en) | 2011-11-30 | 2018-09-26 | Children's Hospital Medical Center | Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support |
| SG11201607035YA (en) | 2014-02-24 | 2016-09-29 | Childrens Hosp Medical Center | Methods and compositions for personalized pain management |
| EP3177738B1 (en) | 2014-08-08 | 2019-10-09 | Children's Hospital Medical Center | Diagnostic method for distinguishing forms of esophageal eosinophilia |
| JP6702686B2 (ja) * | 2015-10-09 | 2020-06-03 | 株式会社エムティーアイ | 表現型推定システム及び表現型推定プログラム |
| EP3402572B1 (en) | 2016-01-13 | 2022-03-16 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| JP7053648B2 (ja) * | 2016-11-23 | 2022-04-12 | アシュレックス ヘルス，インコーポレイテッド | オピオイド中毒を治療するための方法 |
| EP3571309A4 (en) | 2017-01-20 | 2020-11-25 | Children's Hospital Medical Center | METHODS AND COMPOSITIONS RELATED TO THE METHYLATION OF OPRM1 DNA TO MANAGE PAIN IN PEOPLE |
| CN107169573A (zh) * | 2017-05-05 | 2017-09-15 | 第四范式（北京）技术有限公司 | 利用复合机器学习模型来执行预测的方法及系统 |
| US11859250B1 (en) | 2018-02-23 | 2024-01-02 | Children's Hospital Medical Center | Methods for treating eosinophilic esophagitis |
| US12360103B2 (en) | 2018-04-20 | 2025-07-15 | Children's Hospital Medical Center | Blood biomarker for eosinophilic gastrointestinal disorders |
| JP7078458B2 (ja) * | 2018-05-30 | 2022-05-31 | 株式会社Soken | 操舵角決定装置、および、自動運転車 |
| CN108929913A (zh) * | 2018-08-21 | 2018-12-04 | 潍坊德诺泰克生物科技有限公司 | 用于检测rs2032582的引物探针组及其应用 |
| WO2020089835A1 (en) * | 2018-10-31 | 2020-05-07 | Ancestry.Com Dna, Llc | Estimation of phenotypes using dna, pedigree, and historical data |
| CN109741826B (zh) * | 2018-12-13 | 2022-09-13 | 华中科技大学鄂州工业技术研究院 | 麻醉评估决策树构建方法及设备 |
| EP3902546A4 (en) * | 2018-12-28 | 2022-09-28 | Liu, Xing-liang | METHODS AND SYSTEMS FOR DELIVERING A PERSONALIZED CANNABINOID THERAPY REGIME |
| US12297501B2 (en) | 2019-02-25 | 2025-05-13 | Children's Hospital Medical Center | Methods for diagnosing and treating eosinophilic gastritis |
| EP3935581A4 (en) | 2019-03-04 | 2022-11-30 | Iocurrents, Inc. | DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING |
| CN111312387A (zh) * | 2020-01-16 | 2020-06-19 | 安徽医科大学第一附属医院 | 一种男性慢性前列腺炎/慢性盆腔痛综合征疼痛严重程度预测模型及其建立 |
| US20210407643A1 (en) * | 2020-06-25 | 2021-12-30 | Greenway Dna Inc. | Methods and systems for providing a personalized treatment regimen using cannabinoid or psychedelic compounds |
| US12243629B2 (en) * | 2022-09-30 | 2025-03-04 | Cilag Gmbh International | Capacity to adjust patient consent |
| CN115976190B (zh) * | 2022-11-15 | 2024-08-27 | 苏州吉赛基因测序科技有限公司 | 剖宫产患者术后镇痛用药相关基因分型检测的产品及用途 |
| CN119662844A (zh) * | 2024-12-16 | 2025-03-21 | 郑州大学第一附属医院 | 用于麻醉用药基因分型的复合扩增体系、检测方法及试剂盒 |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US5148483A (en) | 1983-08-11 | 1992-09-15 | Silverman Stephen E | Method for detecting suicidal predisposition |
| US4675904A (en) | 1983-08-11 | 1987-06-23 | Compusonics, Inc. | Method for detecting suicidal predisposition |
| US5976081A (en) | 1983-08-11 | 1999-11-02 | Silverman; Stephen E. | Method for detecting suicidal predisposition |
| GB8810400D0 (en) | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| US6054270A (en) | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5288644A (en) | 1990-04-04 | 1994-02-22 | The Rockefeller University | Instrument and method for the sequencing of genome |
| US6287850B1 (en) | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
| EP0695941B1 (en) | 1994-06-08 | 2002-07-31 | Affymetrix, Inc. | Method and apparatus for packaging a chip |
| US6300063B1 (en) | 1995-11-29 | 2001-10-09 | Affymetrix, Inc. | Polymorphism detection |
| EP2369007B1 (en) | 1996-05-29 | 2015-07-29 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| US6429027B1 (en) | 1998-12-28 | 2002-08-06 | Illumina, Inc. | Composite arrays utilizing microspheres |
| US8301468B2 (en) | 2000-05-15 | 2012-10-30 | Optuminsight, Inc. | System and method of drug disease matching |
| DK1816214T3 (da) | 2000-07-11 | 2008-10-27 | Kirk Hogan | Fremgangsmåde og sammensætninger til perioperativ, genomisk profilering |
| US7062443B2 (en) | 2000-08-22 | 2006-06-13 | Silverman Stephen E | Methods and apparatus for evaluating near-term suicidal risk using vocal parameters |
| US7139699B2 (en) | 2000-10-06 | 2006-11-21 | Silverman Stephen E | Method for analysis of vocal jitter for near-term suicidal risk assessment |
| US20030092019A1 (en) | 2001-01-09 | 2003-05-15 | Millennium Pharmaceuticals, Inc. | Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia |
| AU2002366713A1 (en) | 2001-12-20 | 2003-07-09 | Incyte Genomics, Inc. | Nucleotide polymorphisms associated with osteoarthritis |
| US7716207B2 (en) | 2002-02-26 | 2010-05-11 | Odom Paul S | Search engine methods and systems for displaying relevant topics |
| WO2005105093A2 (en) | 2003-08-26 | 2005-11-10 | Duke University | METHOD OF ARRESTING THE SIDE EFFECTS OF µ-OPIOID RECEPTOR AGONISTS DURING THEIR ADMINISTRATION |
| WO2005095601A1 (ja) * | 2004-03-31 | 2005-10-13 | Tokyo Metropolitan Organization For Medical Research | ミューオピオイド受容体遺伝子解析による薬物感受性の評価方法 |
| WO2006119343A1 (en) | 2005-05-03 | 2006-11-09 | Children's Hospital Medical Center | Determination of eosinophilic esophagitis |
| CA2631675A1 (en) * | 2005-11-30 | 2007-06-21 | The University Of North Carolina At Chapel Hill | Identification of genetic polymorphic variants associated with somatosensory disorders and methods of using the same |
| US7754428B2 (en) | 2006-05-03 | 2010-07-13 | The Chinese University Of Hong Kong | Fetal methylation markers |
| JP5308644B2 (ja) | 2006-08-31 | 2013-10-09 | 公益財団法人東京都医学総合研究所 | Ｇｉｒｋチャネル遺伝子解析による薬物感受性の評価方法 |
| US7899764B2 (en) | 2007-02-16 | 2011-03-01 | Siemens Aktiengesellschaft | Medical ontologies for machine learning and decision support |
| JPWO2008133329A1 (ja) | 2007-04-25 | 2010-07-29 | 財団法人 東京都医学研究機構 | Ｐｏｍｃ遺伝子解析による薬物感受性の評価方法 |
| WO2009067473A2 (en) | 2007-11-20 | 2009-05-28 | Wisconsin Alumni Research Foundation | Method of improving palliative care |
| US8249225B2 (en) | 2008-03-14 | 2012-08-21 | International Business Machines Corporation | Identifying caller preferences based on voice print analysis |
| US20110257098A1 (en) | 2008-11-26 | 2011-10-20 | Merck Serono S.A. | Compositions and methods for treating growth hormone deficiency |
| US8497066B2 (en) | 2008-12-04 | 2013-07-30 | Rush University Medical Center | DNA methylation based test for monitoring efficacy of treatment |
| EP3522172B1 (en) | 2009-04-27 | 2021-10-20 | Children's Hospital Medical Center | Method for assessing a neuropsychiatric condition of a human subject |
| GB2483108A (en) | 2010-08-27 | 2012-02-29 | Walid Juffali | Monitoring neurological electrical signals to detect the onset of a neurological episode |
| JP6053267B2 (ja) | 2010-09-03 | 2016-12-27 | 公益財団法人東京都医学総合研究所 | アドレナリン受容体遺伝子解析による薬物感受性および疾患脆弱性の評価方法 |
| US8694335B2 (en) | 2011-02-18 | 2014-04-08 | Nuance Communications, Inc. | Methods and apparatus for applying user corrections to medical fact extraction |
| US9928344B2 (en) | 2011-06-21 | 2018-03-27 | Children's Hospital Medical Center | Diagnostic methods of eosinophilic esophagitis |
| EP2785874B1 (en) | 2011-11-30 | 2018-09-26 | Children's Hospital Medical Center | Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support |
| CA2865154A1 (en) | 2012-02-24 | 2013-08-29 | Children's Hospital Medical Center | Esophageal microrna expression profiles in eosinophilic esophagitis |
| WO2013155010A1 (en) | 2012-04-09 | 2013-10-17 | Children's Hospital Medical Center | Non-invasive biomarkers for eosinophilic esophagitis |
| US8377657B1 (en) | 2012-05-15 | 2013-02-19 | Predictive Biosciences Corporation | Primers for analyzing methylated sequences and methods of use thereof |
| US10132809B2 (en) | 2012-10-10 | 2018-11-20 | Rhote Island Hospital | Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis |
| WO2014190269A1 (en) | 2013-05-24 | 2014-11-27 | Children's Hospital Medical Center | System and method for assessing suicide risk of a patient based upon non-verbal characteristics of voice data |
| US20160180041A1 (en) | 2013-08-01 | 2016-06-23 | Children's Hospital Medical Center | Identification of Surgery Candidates Using Natural Language Processing |
| SG11201607035YA (en) | 2014-02-24 | 2016-09-29 | Childrens Hosp Medical Center | Methods and compositions for personalized pain management |
| EP3177738B1 (en) | 2014-08-08 | 2019-10-09 | Children's Hospital Medical Center | Diagnostic method for distinguishing forms of esophageal eosinophilia |
| EP3571309A4 (en) | 2017-01-20 | 2020-11-25 | Children's Hospital Medical Center | METHODS AND COMPOSITIONS RELATED TO THE METHYLATION OF OPRM1 DNA TO MANAGE PAIN IN PEOPLE |
| US20210205346A1 (en) | 2018-06-28 | 2021-07-08 | Children's Hospital Medical Center | Methods and compositions relating to personalized pain management |
-
2015
- 2015-02-23 SG SG11201607035YA patent/SG11201607035YA/en unknown
- 2015-02-23 JP JP2016570925A patent/JP6581117B2/ja not_active Expired - Fee Related
- 2015-02-23 KR KR1020167026246A patent/KR20160123385A/ko not_active Withdrawn
- 2015-02-23 CA CA2940422A patent/CA2940422A1/en not_active Abandoned
- 2015-02-23 WO PCT/US2015/017134 patent/WO2015127379A1/en not_active Ceased
- 2015-02-23 CN CN201580021042.6A patent/CN106460042A/zh active Pending
- 2015-02-23 EP EP15707526.8A patent/EP3110968B1/en active Active
- 2015-02-23 US US15/120,087 patent/US10878939B2/en active Active
- 2015-02-23 AU AU2015218692A patent/AU2015218692A1/en not_active Abandoned
-
2016
- 2016-08-21 IL IL247389A patent/IL247389A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017512069A5 (enExample) | ||
| Boardman et al. | Investigating SAPAP3 variants in the etiology of obsessive-compulsive disorder and trichotillomania in the South African white population | |
| JP6700333B2 (ja) | ヘテロ接合性の消失（ｌｏｓｓ ｏｆ ｈｅｔｅｒｏｚｙｇｏｓｉｔｙ）を評価するための方法および材料 | |
| Menard et al. | Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains | |
| Antúnez et al. | The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease | |
| JP6625045B2 (ja) | 相同組換え欠損を評価するための方法および材料 | |
| Beer et al. | Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study | |
| JP2014530819A5 (enExample) | ||
| Aldhorae et al. | Nonsyndromic cleft lip with or without cleft palate in arab populations: Genetic analysis of 15 risk loci in a novel case–control sample recruited in Yemen | |
| Matic et al. | Rescue morphine in mechanically ventilated newborns associated with combined OPRM1 and COMT genotype | |
| Sugino et al. | Association of μ-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting | |
| Bose et al. | Footprints of genetic susceptibility to pulmonary tuberculosis: cytokine gene variants in north Indians | |
| Yoshida et al. | Prediction formulas for individual opioid analgesic requirements based on genetic polymorphism analyses | |
| Kang et al. | Vitamin D receptor gene TaqI, BsmI and FokI polymorphisms in Korean patients with tuberculosis | |
| CN103305594A (zh) | 一种检测结核易感性的检测标靶、引物及试剂 | |
| JP5308644B2 (ja) | Ｇｉｒｋチャネル遺伝子解析による薬物感受性の評価方法 | |
| Kudzi et al. | Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population | |
| Han et al. | CCR5 gene polymorphism is a genetic risk factor for radiographic severity of rheumatoid arthritis | |
| US10954563B2 (en) | Method for predicting the onset of extrapyramidal symptoms (EPS) induced by an antipsychotic-based treatment | |
| Ramasawmy et al. | Polymorphisms in the gene for lymphotoxin-αpredispose to chronic Chagas cardiomyopathy | |
| Kashiwabara et al. | Gene polymorphism and frequencies of the NPC 1L1 Gene (rs2072183, rs217434 and rs217428) in Japanese patients with dyslipidemia | |
| Lee et al. | Polymorphism in the serotonin transporter protein gene in Maltese dogs with degenerative mitral valve disease | |
| Haldenby et al. | Increasing prevalence of a fluoroquinolone resistance mutation amongst Campylobacter jejuni isolates from four human infectious intestinal disease studies in the United Kingdom | |
| Fu et al. | PEAR1 gene polymorphism in a Chinese pedigree with pulmonary thromboembolism | |
| Paximadis et al. | Influence of intragenic CCL3 haplotypes and CCL3L copy number in HIV-1 infection in a sub-Saharan African population |